Back to mobile site

BioScrip (BIOS) Misses Q3 EPS by 28c

November 4, 2015 7:13 AM EST

BioScrip (NASDAQ: BIOS) reported Q3 EPS of ($0.38), $0.28 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $247.2 million versus the consensus estimate of $229.89 million.

For earnings history and earnings-related data on BioScrip (BIOS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings